Tunnel stent technique as an alternative treatment for left main protection in valve-in-valve transcatheter aortic valve implantation.

Autor: Meucci F; Structural Interventional Cardiology Division, Department of Cardiac Thoracic and Vascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Di Muro FM; Structural Interventional Cardiology Division, Department of Cardiac Thoracic and Vascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Martinucci P; Cardiology Division, Nuovo Ospedale San Giovanni di Dio, Florence, Italy., Stolcova M; Structural Interventional Cardiology Division, Department of Cardiac Thoracic and Vascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Di Mario C; Structural Interventional Cardiology Division, Department of Cardiac Thoracic and Vascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy., Cecchi E; General Cardiology Division, Department of Cardiac Thoracic and Vascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
Jazyk: angličtina
Zdroj: Postepy w kardiologii interwencyjnej = Advances in interventional cardiology [Postepy Kardiol Interwencyjnej] 2023 Dec; Vol. 19 (4), pp. 371-374. Date of Electronic Publication: 2023 Dec 22.
DOI: 10.5114/aic.2023.133811
Abstrakt: Competing Interests: One of the authors has received research or educational grants from Abbott, Amgen, Asahi Inteec., AstraZeneca, Boston Scientific, Cardinal Health, CSL Behring, Chiesi, Daiichi Sankyo, Edwards, Medtronic, Menarini, Pfizer, Sanofi, Shockwave, Teleflex and Volcano/Philips; another author reports receiving speaker and consultation fees from Medtronic, Edwards and Boston Scientific. The other authors have no conflict of interest to declare.
Databáze: MEDLINE